K.J. Harrison & Partners Inc Hillstream Bio Pharma Inc. Transaction History

K.J. Harrison & Partners Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 27, 2022	SELL	$0.67 - $1.51 $15,678 - $35,334	-23,400 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$1.16 - $4.1 $27,143 - $95,939	23,400 New	23,400 $37,000

Ticker HILS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,529,900
Market Cap $33.2M
Description
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a ...

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

Stay updated on K.J. Harrison & Partners Inc with notifications on news.